A5037728621- Cardiac Imaging and Diagnostics
- Acute Myocardial Infarction Research
- Coronary Interventions and Diagnostics
- Acute Kidney Injury Research
- Lipoproteins and Cardiovascular Health
- Cardiac Structural Anomalies and Repair
- Cardiac Valve Diseases and Treatments
- Cardiovascular Function and Risk Factors
- Antiplatelet Therapy and Cardiovascular Diseases
- Mechanical Circulatory Support Devices
- Chronic Kidney Disease and Diabetes
- Cardiac electrophysiology and arrhythmias
- Atrial Fibrillation Management and Outcomes
- Trauma, Hemostasis, Coagulopathy, Resuscitation
- Cardiac Arrhythmias and Treatments
- Hemodynamic Monitoring and Therapy
- Cardiac, Anesthesia and Surgical Outcomes
- Renal and Vascular Pathologies
- Ancient Mediterranean Archaeology and History
- Heart Rate Variability and Autonomic Control
- Cardiovascular Syncope and Autonomic Disorders
- Cardiac pacing and defibrillation studies
- Traumatic Brain Injury and Neurovascular Disturbances
- Vascular Procedures and Complications
- Heart Failure Treatment and Management
Azienda Usl Toscana Centro
2025
Hospital of Prato
2013-2024
University of Florence
1987-2023
Nuovo Ospedale di Prato
2019-2023
Azienda Ospedaliero-Universitaria Careggi
2023
Ospedale Misericordia e Dolce
2004-2016
Brigham and Women's Hospital
2013
Piedmont University
2013
Università degli Studi del Piemonte Orientale “Amedeo Avogadro”
2013
University of Sassari
2003
The temporal evolution of renal function in patients with acute kidney injury after contrast medium (CI-AKI) is not well known. aim this observational study was to evaluate the incidence, risk factors, and prognostic implications persistent damage (RD) preexistent moderate-to-severe dysfunction.From June 2003 March 2008, 3986 underwent coronary angiography at our institution; 1490 had an estimated creatinine clearance <60 mL/min were enrolled. CI-AKI defined as absolute increase ≥ 0.5 mg/dL...
Background— Intravascular volume expansion represents a beneficial measure against contrast-induced acute kidney injury (CI-AKI) in patients undergoing elective angiographic procedures. However, the efficacy of this preventive strategy has not yet been established for with ST-elevation–myocardial infarction (STEMI), who are at higher risk complication after primary percutaneous coronary intervention (PCI). In randomized study we investigated possible role periprocedural intravenous and...
Objectives To develop a simplified scoring system based on preprocedure clinical characteristics to predict contrast-induced nephropathy (CIN) before elective coronary angiography and percutaneous intervention (PCI). Background CIN is associated with increased mortality morbidity following PCI accounts for hospital costs. Methods Several baseline of 1218 patients were considered as candidate univariate predictors (increase ≥0.5 mg/dl in serum creatinine within 5 days after contrast...
Abstract In this prospective randomized trial on patients with acute myocardial infarction (AMI) treated primary percutaneous coronary intervention (PCI), we hypothesized that abciximab administered intracoronarily, downstream of the occlusion, leads to a greater degree salvage and better left ventricular function recovery compared usual administration. Forty‐five consecutive first AMI infarct‐related artery TIMI flow 0–1 undergoing PCI were enrolled. Twenty‐two randomly assigned...
Adverse cardiovascular events often recur after acute coronary syndrome (ACS), despite secondary prevention measures. Residual risk involves various inflammatory, metabolic and renal factors as well lipid thrombotic processes. This cohort study investigates the relationship between four biomarkers at 1 month ACS all-cause death within 3 years in patients treated with early invasive strategy high-intensity statins from admission. Levels of residual for were: low-density lipoprotein...